Health

Sanofi Drug Withdrawal Due to Political Interference

Updated 2026-05-06 16:35 UTC 1 source Negative

Sanofi requested the FDA to remove its type 1 diabetes drug from Commissioner Marty Makary’s new expedited review program after political appointee interference. The move highlights tensions within regulatory processes.

Coverage timeline — 1 article

STAT News

STAT+: Sanofi asks to pull diabetes drug out of FDA voucher program after political appointee interfered with review

Sanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.

2026-05-06 16:16 UTC